The JAK1/2 Inhibitor Ruxolitinib Reverses Interleukin-6-Mediated Suppression of Drug-Detoxifying Proteins in Cultured Human HepatocytesMarie Febvre-James, Olivier Fardel|Drug Metabolism and Disposition|2017Cited by 41